Transoral Endoscopic Vestibular Approach for Management of Thyroid Malignancies



The United States has seen an apparent increase in the incidence of thyroid cancer over the last three decades. Much debate is had on whether this temporal change represents a true increase in incidence or greater diagnostic sensitivity of thyroid pathology. There has however been a consensus on the relative benign clinical behavior of well-differentiated thyroid cancer which has resulted in a paradigm shift in the management thyroid malignancy with greater emphasis on risk stratification and de-escalation of intervention. As a result of these trends, there has been an increase interest in minimally invasive surgical approaches to the thyroid gland. This chapter investigates these trends and evaluates the role of endoscopic approaches in the management of thyroid malignancies.


Thyroid malignancy Endoscopic surgery Thyroid surgery guidelines 


  1. 1.
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164.CrossRefGoogle Scholar
  2. 2.
    Russell JO, Clark J, Noureldine SI, Anuwong A, Al Khadem MG, Yub Kim H, et al. Transoral thyroidectomy and parathyroidectomy – a North American series of robotic and endoscopic transoral approaches to the central neck. Oral Oncol. 2017;71:75–80.CrossRefGoogle Scholar
  3. 3.
    Berber E, Bernet V, Fahey TJ, Kebebew E, Shaha A, Stack BC, et al. American Thyroid Association statement on remote-access thyroid surgery. Thyroid. 2016;26(3):331–7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bärlehner E, Benhidjeb T. Cervical scarless endoscopic thyroidectomy: axillo-bilateral-breast approach (ABBA). Surg Endosc. 2008;22(1):154–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Jackson NR, Yao L, Tufano RP, Kandil EH. Safety of robotic thyroidectomy approaches: meta-analysis and systematic review. Head Neck. 2014;36(1):137–43.CrossRefGoogle Scholar
  6. 6.
    Kandil EH, Noureldine SI, Yao L, Slakey DP. Robotic transaxillary thyroidectomy: an examination of the first one hundred cases. J Am Coll Surg. 2012;214(4):558–64; discussion 564–6.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Lee J, Yun JH, Nam KH, Soh E-Y, Chung WY. The learning curve for robotic thyroidectomy: a multicenter study. Ann Surg Oncol. 2011;18(1):226–32.CrossRefGoogle Scholar
  8. 8.
    Ohgami M, Ishii S, Arisawa Y, Ohmori T, Noga K, Furukawa T, et al. Scarless endoscopic thyroidectomy: breast approach for better cosmesis. Surg Laparosc Endosc Percutan Tech. 2000;10(1):1–4.CrossRefGoogle Scholar
  9. 9.
    Shimazu K, Shiba E, Tamaki Y, Takiguchi S, Taniguchi E, Ohashi S, et al. Endoscopic thyroid surgery through the axillo-bilateral-breast approach. Surg Laparosc Endosc Percutan Tech. 2003;13(3):196–201.CrossRefGoogle Scholar
  10. 10.
    Terris DJ, Singer MC, Seybt MW. Robotic facelift thyroidectomy: II. Clinical feasibility and safety. Laryngoscope. 2011;121(8):1636–41.CrossRefGoogle Scholar
  11. 11.
    Yoon JH, Park CH, Chung WY. Gasless endoscopic thyroidectomy via an axillary approach: experience of 30 cases. Surg Laparosc Endosc Percutan Tech. 2006;16(4):226–31.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hüscher CS, Chiodini S, Napolitano C, Recher A. Endoscopic right thyroid lobectomy. Surg Endosc. 1997;11(8):877.CrossRefGoogle Scholar
  13. 13.
    Gagner M, Inabnet WB. Endoscopic thyroidectomy for solitary thyroid nodules. Thyroid. 2001;11(2):161–3.CrossRefGoogle Scholar
  14. 14.
    Miccoli P. Minimally invasive surgery for thyroid and parathyroid diseases. Surg Endosc. 2002;16(1):3–6.CrossRefGoogle Scholar
  15. 15.
    Ryu HR, Kang S-W, Lee SH, Rhee KY, Jeong JJ, Nam K-H, et al. Feasibility and safety of a new robotic thyroidectomy through a gasless, transaxillary single-incision approach. J Am Coll Surg. 2010;211(3):e13–9.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Wilhelm T, Metzig A. Endoscopic minimally invasive thyroidectomy (eMIT): a prospective proof-of-concept study in humans. World J Surg. 2011;35(3):543–51.CrossRefGoogle Scholar
  17. 17.
    Lee HY, Richmon JD, Walvekar RR, Holsinger C, Kim HY. Robotic transoral periosteal thyroidectomy (TOPOT): experience in two cadavers. J Laparoendosc Adv Surg Tech A. 2015;25(2):139–42.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Ikeda Y, Takami H, Niimi M, Kan S, Sasaki Y, Takayama J. Endoscopic thyroidectomy by the axillary approach. Surg Endosc. 2001;15(11):1362–4.CrossRefGoogle Scholar
  19. 19.
    Ikeda Y, Takami H, Sasaki Y, Takayama J, Niimi M, Kan S. Comparative study of thyroidectomies. Endoscopic surgery versus conventional open surgery. Surg Endosc. 2002;16(12):1741–5.CrossRefGoogle Scholar
  20. 20.
    Lee KE, Rao J, Youn Y-K. Endoscopic thyroidectomy with the da Vinci robot system using the bilateral axillary breast approach (BABA) technique: our initial experience. Surg Laparosc Endosc Percutan Tech. 2009;19(3):e71–5.CrossRefGoogle Scholar
  21. 21.
    Russell JO, Noureldine SI, Al Khadem MG, Tufano RP. Minimally invasive and remote-access thyroid surgery in the era of the 2015 American Thyroid Association guidelines. Laryngoscope Investig Otolaryngol. 2016;1(6):175–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Richmon JD, Pattani KM, Benhidjeb T, Tufano RP. Transoral robotic-assisted thyroidectomy: a preclinical feasibility study in 2 cadavers. Head Neck. 2011;33(3):330–3.PubMedGoogle Scholar
  23. 23.
    Clark JH, Kim HY, Richmon JD. Transoral robotic thyroid surgery. Gland Surg. 2015;4(5):429–34.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Anuwong A. Transoral endoscopic thyroidectomy vestibular approach: a series of the first 60 human cases. World J Surg. 2016;40(3):491–7.CrossRefGoogle Scholar
  25. 25.
    Anuwong A, Ketwong K, Jitpratoom P, Sasanakietkul T, Duh Q-Y. Safety and outcomes of the transoral endoscopic thyroidectomy vestibular approach. JAMA Surg. 2018;153(1):21–7.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–22.CrossRefGoogle Scholar
  27. 27.
    Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid. 2015;25(9):999–1007.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:1–10.CrossRefGoogle Scholar
  29. 29.
    Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375(7):614–7.CrossRefGoogle Scholar
  30. 30.
    Davies L, Morris LGT, Haymart M, Chen AY, Goldenberg D, Morris J, et al. American Association of Clinical Endocrinologists and American College of endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract. 2015;21(6):686–96.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer. 1985;56(3):531–8.CrossRefGoogle Scholar
  32. 32.
    Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, Lasso-Oria C, Ballestin-Carcavilla C. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71(12):4022–9.CrossRefGoogle Scholar
  33. 33.
    Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955;15(10):1270–80.CrossRefGoogle Scholar
  34. 34.
    Sosa JA, Duh Q-Y, Doherty G. Striving for clarity about the best approach to thyroid cancer screening and treatment: is the pendulum swinging too far? JAMA Surg. 2017;152(8):721–2.CrossRefGoogle Scholar
  35. 35.
    Wiest PW, Hartshorne MF, Inskip PD, Crooks LA, Vela BS, Telepak RJ, et al. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med. 1998;17(8):487–96.CrossRefGoogle Scholar
  36. 36.
    Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968;69(3):537–40.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol. 1977;7(6):481–93.CrossRefGoogle Scholar
  38. 38.
    Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3):226–31.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Investig. 2009;39(8):699–706.CrossRefGoogle Scholar
  40. 40.
    Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22):2400–9.CrossRefGoogle Scholar
  41. 41.
    O’Grady TJ, Gates MA, Boscoe FP. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011. Int J Cancer. 2015;137(11):2664–73.CrossRefGoogle Scholar
  42. 42.
    Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801–7.CrossRefGoogle Scholar
  43. 43.
    Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18(3):784–91.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Malone MK, Zagzag J, Ogilvie JB, Patel KN, Heller KS. Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid. 2014;24(2):314–8.CrossRefGoogle Scholar
  45. 45.
    Thyroid cancer – cancer stat facts [Internet]. [cited 2018 Feb 8]. Available from:
  46. 46.
    Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338.CrossRefGoogle Scholar
  47. 47.
    Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017;24(5):332–6.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.CrossRefGoogle Scholar
  50. 50.
    Perrier ND. Why I have abandoned robot-assisted transaxillary thyroid surgery. Surgery. 2012;152(6):1025–6.CrossRefGoogle Scholar
  51. 51.
    Thyroid cancer staging calculator [Internet]. American Thyroid Association. [cited 2018 Feb 19]. Available from:
  52. 52.
    Kim BW, Yousman W, Wong WX, Cheng C, McAninch EA. Less is more: comparing the 2015 and 2009 American Thyroid Association guidelines for thyroid nodules and cancer. Thyroid. 2016;26(6):759–64.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Adam MA, Goffredo P, Youngwirth L, Scheri RP, Roman SA, Sosa JA. Same thyroid cancer, different national practice guidelines: when discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome. Surgery. 2016;159(1):41–50.CrossRefGoogle Scholar
  54. 54.
    Pacini F. Why do we need guidelines for differentiated thyroid cancer? Thyroid. 2006;16(2):103–4.CrossRefGoogle Scholar
  55. 55.
    Kovatch KJ, Hoban CW, Shuman AG. Thyroid cancer surgery guidelines in an era of de-escalation. Eur J Surg Oncol EJSO [Internet]. 2018 [cited 2017 May 28];44(3):297–306. Available from:
  56. 56.
    Aschebrook-Kilfoy B, Schechter RB, Shih Y-CT, Kaplan EL, Chiu BC-H, Angelos P, et al. The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomarkers Prev. 2013;22(7):1252–9.CrossRefGoogle Scholar
  57. 57.
    Kumbhar SS, O’Malley RB, Robinson TJ, Maximin S, Lalwani N, Byrd DR, et al. Why thyroid surgeons are frustrated with radiologists: lessons learned from pre- and postoperative US. Radiographics. 2016;36(7):2141–53.CrossRefGoogle Scholar
  58. 58.
    Horvath E, Majlis S, Rossi R, Franco C, Niedmann JP, Castro A, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94(5):1748–51.CrossRefGoogle Scholar
  59. 59.
    Bonavita JA, Mayo J, Babb J, Bennett G, Oweity T, Macari M, et al. Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone? AJR Am J Roentgenol. 2009;193(1):207–13.CrossRefGoogle Scholar
  60. 60.
    Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010;136(11):1055–61.CrossRefGoogle Scholar
  61. 61.
    Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33(5):645–9.CrossRefGoogle Scholar
  62. 62.
    Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104(6):954–62.PubMedGoogle Scholar
  63. 63.
    Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124(6):958–64; discussion 964–6.CrossRefGoogle Scholar
  64. 64.
    Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86(4):1447–63.CrossRefGoogle Scholar
  65. 65.
    Nixon IJ, Ganly I, Patel SG, Palmer FL, Whitcher MM, Tuttle RM, et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy. Surgery. 2012;151(4):571–9.CrossRefGoogle Scholar
  66. 66.
    Vaisman F, Shaha A, Fish S, Michael Tuttle R. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol. 2011;75(1):112–9.CrossRefGoogle Scholar
  67. 67.
    Inabnet WB. Robotic thyroidectomy: must we drive a luxury sedan to arrive at our destination safely? Thyroid. 2012;22(10):988–90.CrossRefGoogle Scholar
  68. 68.
    Cabot JC, Lee CR, Brunaud L, Kleiman DA, Chung WY, Fahey TJ, et al. Robotic and endoscopic transaxillary thyroidectomies may be cost prohibitive when compared to standard cervical thyroidectomy: a cost analysis. Surgery. 2012;152(6):1016–24.CrossRefGoogle Scholar
  69. 69.
    Razavi CR, Russell JO. Indications and contraindications to transoral thyroidectomy. Ann Thyroid [Internet]. 2017;2(5):pii: 12. Available from: Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Otolaryngology – Head and Neck SurgeryThe Johns Hopkins School of MedicineBaltimoreUSA
  2. 2.Department of Otolaryngology – Head and Neck SurgeryUniversity of Texas – Southwestern Medical CenterDallasUSA

Personalised recommendations